Answers are grounded in this paper and cite their sources.
Research on circulating oxidized low-density lipoprotein biomarkers is rapidly accelerating and providing novel insights into the pathophysiology of cardiovascular disease. Future studies will further assess the clinical utility of oxidized low-density lipoprotein biomarkers by determining their prognostic value in the diagnosis and prognosis of cardiovascular disease and will also evaluate the relative merit of specific assays by performing comparative studies.
No takes yet. Share an insight, caveat, or question.
Fraley et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: